C&EN White Paper
Filling Gaps in Drug Discovery Pipelines: From Compound Candidate to Clinical Reality
Brought to you by Curia Global
Overview

In the world of drug discovery, countless potential treatments languish in the “valley of death” that separates promising candidate compounds from clinical implementation. Investigators face high costs, limited technology access, lengthy timelines, and regulatory hurdles. But strategic NIH programs are bringing together government, industry, and academic resources to overcome these challenges and deliver new drugs to the patients who need them most. This white paper explores the benefits of these partnerships, with insights and examples from NIH and Curia experts who have been involved for years.

Key Objectives:
  • How programs maximize collaboration and support
  • Pairing deep expertise with unparalleled technology access
  • How investment can unlock otherwise-missed potential


Brought to you by:
Please complete the form to download the white paper.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy